Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
2-amino-5-chlorobenzophenone
EC Number:
211-949-7
EC Name:
2-amino-5-chlorobenzophenone
Cas Number:
719-59-5
Molecular formula:
C13H10ClNO
IUPAC Name:
(2-amino-5-chlorophenyl)(phenyl)methanone
Test material form:
solid: particulate/powder

Method

Target gene:
TA1535: hisG46, uvrB, rfa
TA1537: his C3076, uvrB, rfa
TA100: hisG46, uvrBn rfa, R fact
TA98: his D3052, uvrb, rfa, R fact
WP2 uvrA: B/r/WP2
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
Range finding : 10, 100, 500, 1000, 3000 μg/plate
Main study: 2, 10, 30, 60, 100, 200 μg/plate (without S9 mix)or 10, 30, 60, 100, 200 μg/plate (with S9 mix)
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
yes
True negative controls:
not specified
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
N-ethyl-N-nitro-N-nitrosoguanidine
other: 2-aminoanthracene ; 1-methyl-3-nitro-1-nitrosoguanidine

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not specified
Positive controls validity:
valid
Remarks on result:
other: Cytotoxicity is starting generally at 100 μg/plate without S9 mix and at 200 μg/plate with S9 mix

Any other information on results incl. tables

Introduction of mutations in the absence of a metabolizing system (rat S9)

 

Experiment 1

 

Substance

Conc.

(μg/plate)

Number of reverants per plate

TA 1535

TA 1537

TA 100

TA 98

WP2 uvrA

Solvant control

(DSO 100μl/pl.)

 

11+-3

8+-3

131+-6

22+-13

21+-1

2-amino-5-chloro-benzophenone

2

8+-4

7+-1

127+-21

20+-6

20+-6

 

10

6+-2

9+-3

128+-17

18+-1

20+-2

 

30

10+-1

9+-5

135+-26

18+-6

32+-1

 

60

9+-6

11+-6

110+-5

17+-1

23+-7

 

100P

5+-2

10+-2

109+-16

19+-2

23+-5

 

200PP

0

0

0

0

0

Control

 

 

 

 

 

 

MNNG

2

>2000

602

965

1551

528

9AA

80

>2000

403

1243

1320

622

2 NF

5

>2000

1554

1282

1541

633

ENNG

2.5

 

720

1163

1471

594

 

Experiment 2

 

Substance

Conc.

(μg/plate)

Number of reverants per plate

TA 1535

TA 1537

TA 100

TA 98

WP2 uvrA

Solvant control

(DSO 100μl/pl.)

 

7+-1

6+-0

108+-16

13+-2

26+-9

2-amino-5-chloro-benzophenone

2

11+-3

6+-1

114+-19

18+-5

28+-5

 

10

9+-3

6+-4

111+-13

17+-1

21+-7

 

30

7+-4

6+-2

125+-19

22+-2

18+-1

 

60

6+-4

6+-4

108+-7

17+-8

26+-2

 

100P

9+-6

4+-1

87+-14

19+-9

23+-4

Control

 

 

 

 

 

 

MNNG

2

1019

857

1241

1165

544

9AA

80

1537

519

1123

1389

452

2NF

5

1522

867

1365

1252

542

ENNG

2.5

1359

748

1243

1269

513

 

Induction of mutations in the presence of a metabolizing system (rat s9)

 

Experiment 1

 

Substance

Conc.

(μg/plate)

Number of reverants per plate

TA 1535

TA 1537

TA 100

TA 98

WP2 uvrA

Solvant control

(DSO 100μl/pl.)

 

8+-3

10+-4

112+-16

26+-2

25+-6

2-amino-5-chloro-benzophenone

10

5+-2

8+-3

117+-11

25+-2

20+-7

 

30

4+-0

7+-4

124+-22

25+-2

25+-7

 

60

8+-3

10+-3

126+-10

21+-3

26+-4

 

100

6+-3

9+-3

131+-12

21+-5

18+-8

 

200P

5+-3

7+-3

99+-15

25+-3

25+-3

Control

 

 

 

 

 

 

2AA

0.5

123

101

278

171

187

 

2.5

108

103

296

161

211

 

5

118

113

301

162

202

 

 

Induction of mutations in the presence of a metabolizing system (hamster s9)

 

Experiment 2

Substance

Conc.

(μg/plate)

Number of reverants per plate

TA 1535

TA 1537

TA 100

TA 98

WP2 uvrA

Solvant control

(DSO 100μl/pl.)

 

7+-2

12+-3

143+-15

28+-7

15+-7

2-amino-5-chloro-benzophenone

10

9+-0

13+-2

119+-2

24+-3

19+-3

 

30

4+-2

9+-2

144+-8

24+-7

25+-2

 

60

6+-3

8+-2

135+-7

22+-4

27+-3

 

100

6+-2

6+-1

117+-14

20+-13

19+-6

 

200P

7+-4

7+-2

92+-9

23+-3

21+-2

Control

 

 

 

 

 

 

2AA

0.5

214

174

>2000

>2000

670

 

2.5

245

217

>2000

>2000

697

 

5

250

201

>2000

>2000

694

Applicant's summary and conclusion

Conclusions:
None of the five tester strains showed increased mutagenie response, either in the absence (2-200μg/plate) or presence (10-200μg/plate) of S9 mix
In conclusion, it can be said that the investigation, under the experimental conditions described, gave no indication of any mutagenic activity of 2-amino-5-chlorobenzophenone in S.typhimurium strains TA1535, TA1537, TA100 and TA98 and E;coli WP2uvrA
Executive summary:

The mutagenic potential of 2-amino-5-ch1orobenzophenone, a degradation product of clorazepate dipotassium, was investigated in the bacteria strains Salmonella typhimurium TA1535, TA1537, TA100 and TA98 AND Escherichia coli WP2uvrA. The study was done using the plate incorporation assay with and without liver homogenate (S9 fraction, both from Aroclor 1254-pretreated male rats and from untreated mal hamsters) as metabolizing system. The concentrations of the test substance assayed had been determined in a pre-experiment and were selected on the strength of the precipitation on the plate and the bacteriotoxicity. In the main study, two independent experiments were carried out. Overall, varius concentrations of 2-amino-5chlorobenophenone ranging from 2 to 200μg/plate in the absence of the metabolizing system and from 10 to 200μg/plate in the presence of the metabolizing system were tested. 9-Aminoacridine, 2-aminoanthracene,1-ethyl-3-nitro-1-nitrosoguanidine, 1-methyl-3-nitro-1-nitrosoguanidine and 2-nitrofluorene served as positive controls to test the mutability of the bacterial strains as well as the activity of the metabolizing system. In the concentrations investigated, 2-amino-5-chlorobenzophenone did not show any mutagenic activity with or without the addition of S9 liver homogenate fractions. Bacteriotoxic effects were observed starting generally at 100μg/plate in the absence of, and at 200μg/plate in the presence of the metabolizing system. Precipitates in the agar were found starting at 100 and 200μg/plate, respectively. The known reversion properties were determined for the tester strains with the control substances; the positive responses confirmed the good metabolic activity of the liver homogenate fractions. It was concluded that the investigation, unde the experimental conditions described, gave no indication of any mutagenic activity of 2-amino-5-chlobenzophenone in S. typhimurium strains TA1535, TA1537, TA100 and TA98 and E.coli WP2uvrA.